After 60 days of follow-up and monitoring, mice harboring Agtr1 KD cells (AT1-shRNA) showed reduced tumor development compared with mice harboring NT-shRNA cells (Fig. 5A). This evidence concerns the gene AGTR1 and neoplasm.